In a strategic move that reshapes the landscape of India’s injectables market, Eris Lifesciences Ltd., a leading player in the branded formulations sector, has announced the acquisition of Biocon Biologics’ India branded formulation business for a hefty sum of INR 1,242 crore. This acquisition not only signifies Eris Lifesciences’ aggressive entry into the burgeoning INR […]
Eris Lifesciences has announced the acquisition of nine cosmetic dermatology brands in the Indian market from Dr. Reddy’s Laboratories for INR 275 crores in cash. According to the Indian pharma company which is based in Ahmedabad, the deal helps supplement and grow its cosmetic dermatology business through the increase of its product offerings. The brands […]
Glenmark Pharmaceuticals has agreed to sell certain brands from its dermatology segment in India and Nepal to Eris Oaknet Healthcare, a fully-owned subsidiary of Eris Lifesciences. The consideration for the deal is INR 340.48 crores, stated the Indian pharma company. The brands being divested are Onabet, Sorvate, Halovate, Demelan, Luligee, Aceret, Revize, Dosetil, and Powercort, […]